Killer Inhibitory Receptor CD158a Overexpression Among Natural Killer Cells in Women With Endometriosis is Undiminished by Laparoscopic Surgery and Gonadotropin Releasing Hormone Agonist Treatment*
article
OA: closed
CC0
⤵ 20 in-corpus citations
AI-generated summary
Women with endometriosis show higher percentages of CD158a-expressing NK cells in blood and peritoneal fluid, an elevation unaffected by surgery or GnRHa treatment.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
PROBLEM: Natural killer (NK) dysfunction is considered to contribute to the pathogenesis of endometriosis. In this study, we investigated the host immune response to endometriosis in terms of killer inhibitory receptor (KIR) expression by NK cells. METHOD OF STUDY: We compared cells from Japanese women laparoscopically diagnosed with endometriosis and treated with laparoscopic surgery (n = 98), 1 month after laparoscopic surgery (n = 36), and 12 weeks after gonadotropin releasing hormone agonist (GnRHa) treatment (n = 18) to cells from 104 women with other laparoscopic diagnoses. KIR expression by NK cells was assessed in peripheral blood and peritoneal fluid samples by flow cytometry. RESULTS: In women with endometriosis, the percentage of CD158a-expressing cells among CD16-expressing NK (CD158a(+)NK) cells in both peritoneal fluid and peripheral blood was significantly higher than in control subjects. No significant differences in proportion of CD158a(+)NK cells were identified between peripheral blood NK cells sampled before and 1 month after laparoscopic surgery, or 12 weeks after initiating GnRHa treatment. CONCLUSIONS: Increased percentage of CD158a(+)NK cells in peripheral blood from women with endometriosis was undiminished by laparoscopic surgery and GnRHa treatment; the persistence of CD158a(+)NK cell excess is probably related to NK cell suppression in endometriosis. This overexpression may represent a risk factor for development of endometriosis and its recurrence after treatments.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (29)
- Decreased Natural Killer Cell Activity in Women with Endometriosis via openalex
- Family trait analysis: A case-control study of 43 women with endometriosis and their best friends via openalex
- Heritable aspects of endometriosis via openalex
- Heritage aspects of endometriosis. II. Clinical characteristics of familial endometriosis. via openalex
- Immunomodulation in women with endometriosis receiving GnRH agonist via openalex
- Increased killer inhibitory receptor KIR2DL1 expression among natural killer cells in women with pelvic endometriosis via openalex
- Increase in the expression of killer cell inhibitory receptors on peritoneal natural killer cells in women with endometriosis via openalex
- Modern concepts of endometriosis. Classification and its consequences for therapy. via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Post-operative GnRH analogue treatment after conservative surgery for symptomatic endometriosis stage III–IV: a randomized controlled trial via openalex
- W11141567 via openalex
- W2098130458 via openalex
- W2131709101 via openalex
- W2139014493 via openalex
- W2154901790 via openalex
- W2161165126 via openalex
- W2179076164 via openalex
- W2343955274 via openalex
- W2417327597 via openalex
- W2080526547 via openalex
- W141728048 via openalex
- W1972563403 via openalex
- W2005347029 via openalex
- W2015899133 via openalex
- W2020882777 via openalex
- W2024318122 via openalex
- W2028587418 via openalex
- W2038967602 via openalex
- W2057401214 via openalex
Cited by (20)
- Factors associated with recurrent endometriomas after surgical excision 2023
- Myeloid-derived suppressor cells: A new emerging player in endometriosis 2023
- Peritoneal natural killer cell chemotaxis is decreased in women with pelvic endometriosis 2022
- Natural Killer Cell Receptors and Endometriosis: A Systematic Review 2022
- Pelvic endometriosis and natural killer cell immunity 2020
- Reccurence of endometrioid ovarian cysts and possible ways to its reduce 2020
- NK Cells as Potential Targets for Immunotherapy in Endometriosis 2019
- Platelets impair natural killer cell reactivity and function in endometriosis through multiple mechanisms 2017
- Decreased peritoneal NK cell movement in women with endometriosis by time-lapse imaging estimation 2017
- Blood biomarkers for the non-invasive diagnosis of endometriosis 2016
- Natural Killer Cells: Key Players in Endometriosis 2015
- Clinical markers of endometriosis: Have we been too quick to judge? 2014
- Role of NK Cells in Endometriosis 2014
- Recurrence of endometriosis; risk factors, mechanisms and biomarkers; review of the literature 2013
- Endometriosis: ways of the decision of a problem to the XXI century 2011
- Peripheral biomarkers of endometriosis: a systematic review 2010
- Killer Immunoglobulin‐like Receptor and Human Leukocyte Antigen Expression as Immunodiagnostic Parameters for Pelvic Endometriosis 2006
- Comparison of RCAS1 and metallothionein expression and the presence and activity of immune cells in human ovarian and abdominal wall endometriomas 2006
- Role of immunologic and inflammatory factors in the development of endometriosis: indications for treatment strategies 2005
- Role of immunologic and inflammatory factors in the development of endometriosis: indications for treatment strategies 2005
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:12:32.173627+00:00
License: CC0
· commercial use OK